|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-6-3
|
|
pubmed:abstractText |
Some transplant-related complications, such as the engraftment syndrome, are thought to be mediated by cytokines released during expansion of hematopoietic progenitors at the time of neutrophil recovery. Since there is an inverse correlation between CD34(+) cell dose and time to neutrophil recovery, we sought to determine if peritransplant toxicity and early mortality were adversely affected by high CD34(+) cell doses.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1465-3249
|
|
pubmed:author |
pubmed-author:BraunschweigII,
pubmed-author:ChamplinRR,
pubmed-author:GajewskiJJ,
pubmed-author:GeeA PAP,
pubmed-author:GeislerDD,
pubmed-author:HuhY OYO,
pubmed-author:KörblingMM,
pubmed-author:LauppeJJ,
pubmed-author:MehraRR,
pubmed-author:MirzaN QNQ,
pubmed-author:PrzepiorkaDD,
pubmed-author:RondonGG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
105-10
|
|
pubmed:dateRevised |
2008-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12042047-Adult,
pubmed-meshheading:12042047-Aged,
pubmed-meshheading:12042047-Antigens, CD34,
pubmed-meshheading:12042047-Blood Component Removal,
pubmed-meshheading:12042047-Blood Transfusion, Autologous,
pubmed-meshheading:12042047-Breast Neoplasms,
pubmed-meshheading:12042047-Female,
pubmed-meshheading:12042047-Hematopoietic Stem Cell Mobilization,
pubmed-meshheading:12042047-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:12042047-Humans,
pubmed-meshheading:12042047-Middle Aged,
pubmed-meshheading:12042047-Survival Rate,
pubmed-meshheading:12042047-Time Factors,
pubmed-meshheading:12042047-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer.
|
|
pubmed:affiliation |
Department of Blood and Marrow Transplantation, MD Anderson Cancer Center, University of Texas, 6565 Fannin Street, Houston, TX 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
